Does EVOLOCUMAB Cause Dyspnoea? 1,937 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 1,937 reports of Dyspnoea have been filed in association with EVOLOCUMAB (REPATHA). This represents 1.3% of all adverse event reports for EVOLOCUMAB.
1,937
Reports of Dyspnoea with EVOLOCUMAB
1.3%
of all EVOLOCUMAB reports
15
Deaths
299
Hospitalizations
How Dangerous Is Dyspnoea From EVOLOCUMAB?
Of the 1,937 reports, 15 (0.8%) resulted in death, 299 (15.4%) required hospitalization, and 39 (2.0%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 1,937 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which EVOLOCUMAB Alternatives Have Lower Dyspnoea Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE